FilingReader Intelligence

Livzon Pharma acquires majority stake in Vietnamese company

May 22, 2025 at 05:01 PM UTCBy FilingReader AI

** Livzon Pharmaceutical Group Inc. (HKEX:1513) has announced a discloseable transaction to acquire 64.81% of the issued shares in Imexpharm Corporation, a Vietnamese pharmaceutical company, for VND 5,730,815,426,000. The acquisition, executed via Livzon's indirect wholly-owned subsidiary, will see Imexpharm become an indirect non-wholly owned subsidiary, with its financial results consolidated into Livzon's statements. The deal is subject to customary conditions, including regulatory approvals and absence of material adverse changes. The transaction is categorized as discloseable as one or more applicable percentage ratios exceed 5% but are less than 25%, and the Acquisition will be funded by the Group's internal resources. Imexpharm, listed on the HOSE, focuses on research, development, manufacturing, and distribution of pharmaceutical products, primarily antibiotics and cardiovascular drugs. The Acquisition will solidify a foundation for Group's further expansion into overseas markets.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Livzon Pharmaceutical Group Inc publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →